Verified by AISci
Public source attached
Source status for this paper in the current AISci reviewed snapshot.
- Primary source
- ClinicalTrials.gov
- Correction status
- none
- Evidence coverage
- 1 sources / 1 publishers
- Last metadata check
- Jul 19, 2026
Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant (NCT05948540)
Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant | Phase: PHASE2 | Conditions: Post Traumatic Stress Disorder
SourceClinicalTrials.govVerified by AISci
Source status for this paper in the current AISci reviewed snapshot.
AI Reading Notes
Structured notes generated from source-linked AISci metadata. Treat them as a reading aid, not a substitute for the paper.
Research Workflow
Recommended next steps for turning this signal into research action.
No reviewed author edge is attached to this output.
No source-confirmed author affiliation is attached.
Controlled AISci Stage A topic for Clinical and Regulatory.
Clinical/translation signal: Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant
Organization linked by public source evidence.